We’re pleased to announce that Tony O’Brien has joined the HN Board as a Non-Executive Director, as of 1 October 2022.
Tony is former Director General for the Health Service Executive (HSE) and has extensive experience providing healthcare and strategic counsel on several prominent boards. He is currently a Columnist with The Business Post, specialising in health-related topics.
Tony O’Brien said:
“I’m delighted to be joining the HN Board and look forward to contributing to the company's novel approach to highly targeted secondary prevention for patients with multiple chronic conditions. HN's use of advanced data science and AI for screening high-need patients, combined with the clinical coaching programme, is novel and exciting. It represents a huge opportunity to help patients get the right treatment and care at the right time. I’m particularly impressed by the scientific rigour within HN and the promising market uptake in the UK and Ireland. I'm very excited to be a part of this journey, helping the company achieve its goals.”
Joachim Werr, Founder and Executive Chair of HN, said:
“We’re delighted to have Tony join HN’s Board as a non-executive director. Tony is an accomplished and transformative executive with broad experience in clinical quality and governance, and the board will also benefit from his experience of introducing new product and service offers into healthcare markets.
Find out more about HN’s board and governance here.